logo

ECG

Everus Construction·NYSE
--
--(--)
--
--(--)
0.48 / 10
Underperform

ECG's fundamental analysis is subpar, scoring only 0.5 out of 10. Key weaknesses include low inventory turnover days (5.16) and negative net income-to-revenue (-0.72), while revenue-to-market value (0.68) and profit-to-market value (0.498) offer limited offset. Historical back-tests show negative monthly returns for most factors, reinforcing a prudent outlook and a recommendation to avoid or hedge.

Fundamental(0.48)SentimentTechnical

Analysis Checks(2/10)

Revenue-MV
Value0.68
Score3/3
Weight-34.08%
1M Return12.29%
Profit-MV
Value0.50
Score2/3
Weight-7.71%
1M Return2.68%
Net income-Revenue
Value-0.72
Score1/3
Weight-1.73%
1M Return0.73%
PB-ROE
Value1.65
Score0/3
Weight30.50%
1M Return-8.25%
Non-current liabilities / Total liabilities (%)
Value34.15
Score0/3
Weight8.90%
1M Return-3.51%
Net cash flow from operating activities (YoY growth rate %)
Value31.39
Score0/3
Weight10.18%
1M Return-4.06%
Cash-UP
Value0.74
Score1/3
Weight48.77%
1M Return-18.30%
Asset-MV
Value-0.51
Score0/3
Weight20.57%
1M Return-7.23%
Inventory turnover days
Value5.16
Score0/3
Weight1.78%
1M Return-0.61%
Cash-MV
Value-0.39
Score0/3
Weight22.83%
1M Return-6.44%
Is ECG undervalued or overvalued?
  • ECG scores 0.48/10 on fundamentals and holds a Premium valuation at present. Backed by its 29.43% ROE, 5.18% net margin, 29.94 P/E ratio, 8.66 P/B ratio, and 24.21% earnings growth, these metrics solidify its Underperform investment rating.